Nutriband Inc. Profile Avatar - Palmy Investing

Nutriband Inc.

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transd…

Biotechnology
US, Orlando [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -
End of NTRB's Analysis
CIK: 1676047 CUSIP: 67092M208 ISIN: US67092M2089 LEI: - UEI: -
Secondary Listings
NTRB has no secondary listings inside our databases.